Securities fraud litigation history and active cases
In Litigation
2
Settlement
1
Closed
0
Total Settlement
$18.9M
1:21cv10479 • November 13, 2020
Class Period Start
October 22, 2019
Class Period End
November 6, 2020
PSLRA Deadline
January 12, 2021
Case Allegations
10b5
Statutes of Repose
Oct 22, 2022
Country
United States
Court
Federal Court
26-1488 • May 22, 2024
Class Period Start
September 14, 2020
Class Period End
November 14, 2024
PSLRA Deadline
July 22, 2024
Case Allegations
10b5
Statutes of Repose
Sep 14, 2023
Country
United States
Court
Federal Court
1:22cv10200 • February 7, 2022
Class Period Start
June 8, 2021
Class Period End
October 12, 2021
PSLRA Deadline
April 8, 2022
Case Allegations
10b5
Statutes of Repose
Jun 8, 2024
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
September 24, 2026
Settlement Fund
$18,900,000
Settlement Status
Preliminarily Approved
Settlement Class
All persons or entities that purchased or otherwise acquired Biogen common stock between June 8, 2021 and July 12, 2021, inclusive.
Claim Administrator
Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Ste. 205
Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://biogensecuritieslitigation.com/Hearing Date
September 29, 2026
Opt-out Deadline
August 25, 2026
Settlement Note
Download hereProof Of Claim
Download hereTOP